Difference between revisions of "Hypericum-amitriptyline"

From Psychiatrienet
Jump to: navigation, search
Line 5: Line 5:
 
* Administration of hypericum can be stopped abruptly.
 
* Administration of hypericum can be stopped abruptly.
 
| start =  
 
| start =  
* '''Day 1-7:''' a wash-out period of one week is necessary.
+
* '''Day 1-14:''' a wash-out period of one week is necessary.
* '''Day 8:''' start administration of amitriptyline in a dosage of 25 mg/day.
+
* '''Day 15:''' start administration of amitriptyline in a dosage of 25 mg/day.
 
* If necessary, increase dosage of amitriptyline to 50 mg/day.
 
* If necessary, increase dosage of amitriptyline to 50 mg/day.
 
* Start low, go slow.
 
* Start low, go slow.

Revision as of 16:15, 13 July 2009

Hypericum
Type Antidepressant
Group other
links
EMEA 10130408en
PubMed Hypericum
Kompas (Dutch) hypericum extract
Wikipedia St John's wort
Amitriptyline
Type Antidepressant
Group TCA
links
ATC-code N06AA09
Medscape Amitriptyline
PubChem 2160
PubMed Amitriptyline
Kompas (Dutch) Amitriptyline
Wikipedia Amitriptyline

Switch medication from hypericum to amitriptyline.[1] [2]

Nietinrijdenbord.png Stop hypericum
  • Administration of hypericum can be stopped abruptly.
Eenrichtingbord.png Start amitriptyline
  • Day 1-14: a wash-out period of one week is necessary.
  • Day 15: start administration of amitriptyline in a dosage of 25 mg/day.
  • If necessary, increase dosage of amitriptyline to 50 mg/day.
  • Start low, go slow.
Infobord.png More information
  • Occurrence of the serotonin syndrome is theoretically possible.
  • Hypericum slows the metabolism of amitriptyline via CYP3A4. This effect may persist up to two weeks after stopping hypericum, so caution is necessary.
  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.